Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II)
Technology
E-212-2011
Patent ID
E-212-2011-0-US-03
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
9127056
Publication Number
US20140271646A1
Application Number
14/352,312
IC
NCI
Date Filed
Date Issued